Moderna’s Melanoma Vaccine Breakthrough | Denver News

Moderna’s groundbreaking melanoma vaccine, crafted from a patient’s own tumor and guided by AI, is rewriting the playbook on cancer treatment—helping advanced-stage patients stay cancer-free longer when paired with Keytruda. Results from a massive Phase 3 trial show real-world promise, sending Moderna’s stock soaring as scientists celebrate a major leap in personalized mRNA therapy. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f89f1024aeb702c0